NOS2 and myeloid sarcoma: In the present study, we established a mouse model of gut microbiota dysbiosis and an FMT model using clindamycin treatment and revealed the potential mechanisms of intestinal microbiota dysbiosis promoting MS pulmonary colonization in the mouse by upregulating Nos2 gene-associated pathways.